TABLE I.
Baseline tumour, patient and treatment characteristics for all patients (n=585)
| Characteristic | N | Patients (n=585) |
|---|---|---|
| Age at Diagnosis – mean ± SD, median (min, max) | 585 | 62.8 ± 12.4 |
| 63.0 (22.0, 95.0) | ||
| Stage – n (%) | 525 | |
| I | 125 (23.8) | |
| II | 98 (18.7) | |
| III | 77 (14.7) | |
| IV | 225 (42.9) | |
| T Stage – n (%) | 585 | |
| T1 | 204 (34.9) | |
| T2 | 183 (31.3) | |
| T3 | 55 (9.4) | |
| T4 | 143 (24.4) | |
| N Stage – n (%) | 585 | |
| N0 | 314 (53.7) | |
| N1 | 78 (13.3) | |
| N2 | 122 (20.9) | |
| N3 | 6 (1.0) | |
| NX | 65 (11.1) | |
| Location – n (%) | 585 | |
| Tongue | 276 (47.2) | |
| Palate | 23 (3.9) | |
| Cheek/Buccal/Mucosa | 63 (10.8) | |
| Floor of Mouth | 102 (17.4) | |
| Mandible/Gingiva/Alveolus | 94 (16.1) | |
| Retromolar Trigone | 27 (4.6) |